MRI在肝胆疾病中的应用及挑战

王晓明; 王悦人

doi:10.3969/j.issn.1001-5256.2016.12.002

MRI在肝胆疾病中的应用及挑战

DOI: 10.3969/j.issn.1001-5256.2016.12.002

中国医科大学附属盛京医院放射科

详细信息

中图分类号: R445.2;R575
计量
- 文章访问数: 1772
- HTML全文浏览量: 26
- PDF下载量: 611
- 被引次数: 0
出版历程
- 出版日期: 2016-12-20

Application of magnetic resonance imaging in hepatobiliary diseases and related challenges

摘要

摘要: 我国肝胆疾病高发,且多样化。除慢性病毒性肝炎外,非酒精性脂肪性肝病及酒精性肝病的发生率亦逐年上升。近年来,随着MRI软硬件技术的改进、参数的个性化选择、脉冲序列的变换组合、新型造影剂的使用等,MRI已成为肝胆疾病诊断不可替代的检查手段,但仍面临挑战,重点评述了MRI在肝胆脏疾病中的应用进展和研究难点,探讨进一步提高临床研究水平的发展前景。
- 肝疾病 /
- 胆道疾病 /
- 磁共振成像 /
- 述评
Abstract: Hepatobiliary diseases are highly prevalent and diverse in China. Besides chronic viral hepatitis,the incidence of non- alcoholic fatty liver disease and alcohol liver disease has been increasing gradually year by year. In recent years,with the improvement of magnetic resonance software and hardware technology,individualized selection of parameters,transformation and combination of pulse sequences,and the use of new contrast agents,magnetic resonance imaging( MRI) has become an irreplaceable examination method for hepatobiliary diseases,but still faces great challenges. This article reviews the application of MRI in hepatobiliary diseases and related research difficulties and how to further increase clinical research level in future.
- liver diseases /
- biliary tract diseases /
- magnetic resonance imaging /
- editorial

HTML全文

参考文献(30)

[1]ZHUANG H.Current status and goals of hepatitis B prevention and treatment[J].Chin J Intern Med,2008,47(10):793-795.(in Chinese)庄辉.我国乙型肝炎防治现状及目标[J].中华内科杂志,2008,47(10):793-795.

[2] ZHANG RL,LU LG.Current situation and future prospect of cholangiopathy[J].J Clin Hepatol,2011,27(9):903-905.(in Chinese)张汝玲,陆伦根.胆道疾病的研究现状[J].临床肝胆病杂志,2011,27(9):903-905.

[3]GUO QY,SHI Y.Applications and advances of magnetic resonance imaging in diagnosing liver disease[J].Chin J Magn Reson Imaging,2014,5(s1):10-14.(in Chinese)郭启勇,石喻.磁共振成像在肝病的应用及进展[J].磁共振成像,2014,5(s1):10-14.

[4]CHEN C,WANG B,SHI D,et al.Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis[J].Chin Med J(Engl),2014,127(17):3082-3087.

[5]WOO S,LEE JM,YOON JH,et al.Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma:correlation with enhancement degree and histologic grade[J].Radiology,2014,270(3):758-767.

[6]PARK YS,LEE CH,KIM JH,et al.Using intravoxel incoherent motion(IVIM)MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization:a preliminary result[J].Magn Reson Imaging,2014,32(6):638-646.

[7]KIM JH,JOO I,KIM TY,et al.Diffusion-related MRI parameters for assessing early treatment response of liver metastases to cytotoxic therapy in colorectal cancer[J].AJR,2016,207(3):w26-w32.

[8]WU Q,FU Q,ZHAO H,et al.Application of intravoxel incoherent motion diffusion-weighted imaging in liver diseases[J].J Clin Hepatol,2015,31(10):1744-1746.(in Chinese)吴琼,付旷,赵荟,等.体素内不相干运动扩散加权成像在肝脏疾病诊疗中的应用[J].临床肝胆病杂志,2015,31(10):1744-1746.

[9]STRUYFS H,van HECKE W,VERAART J,et al.Diffusion kurtosis imaging:a possible MRI biomarker for AD diagnosis?[J].J Alzheimers Dis,2015,48(4):937-948.

[10]ZHANG Y,GAO Y,ZHOU M,et al.A diffusional kurtosis imaging study of idiopathic generalized epilepsy with unilateral interictal epileptiform discharges in children[J].J Neuroradiol,2016,43(5):339-345.

[11]ROSENKRANTZ AB,SIGMUND EE,WINNICK A,et al.Assessment of hepatocellular carcinoma using apparent diffusion coefficient and diffusion kurtosis indices:preliminary experience in fresh liver explants[J].Magn Reson Imaging,2012,30(10):1534-1540.

[12]GOSHIMA S,KANEMATSU M,NODA Y.Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma[J].AJR,2015,204(5):543-549.

[13]XU ML,XING CH,CHEN HW,et al.Application value of DKI in grading of extrahepatic cholangiocarcinoma[J].Chin J Magn Reson Imaging,2016,7(1):34-39.(in Chinese)徐蒙莱,邢春华,陈宏伟,等.DKI技术在肝外胆管癌分级中的应用价值[J].磁共振成像,2016,7(1):34-39.

[14]CHEN LH,LIU AL.Applications of diffusional kurtosis tensor imaging in abdomen[J].Chin J Med Imaging Technol,2015,32(4):631-633.(in Chinese)陈丽华,刘爱连.磁共振弥散峰度成像在腹部的应用[J].中国医学影像技术,2015,32(4):631-633.

[15]VENKATESH SK,YIN M,EHMAN RL.Magnetic resonance elastography of liver:clinical applications[J].J Comput Assist Tomogr,2013,37(6):887-896.

[16]XANTHAKOS SA,PODBERESKY DJ,SERAI SD,et al.Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease[J].J Pediatr,2014,164(1):186-188.

[17]DULAI PS,SIRLIN CB,LOOMBA R.MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH:Clinical trials to clinical practice[J].J Hepatol,2016,65(5):1006-1016.

[18]VENKATESH SK,YIN M,GLOCKNER JF,et al.MR elastography of liver tumors:preliminary results[J].AJR,2008,190(6):1534-1540.

[19]SOUCHON R,SALOMIR R,BEUF O,et al.Transient MR elastography(t-MRE)using ultrasound radiation force:theory,safety,and initial experiments in vitro[J].Magn Reson Med,2008,60(4):871-881.

[20]YUAN F,SONG B.The progress and prospect of imaging examination for liver diseases[J].Sichuan Med J,2015,36(5):592-595.(in Chinese)袁放,宋彬.肝脏疾病的影像学检查技术进展与展望[J].四川医学,2015,36(5):592-595.

[21]LEE SS,PARK SH.Radiologic evaluation of nonalcoholic fatty liver disease[J].World J Gastroenterol,2014,20(23):7392-7402.

[22]WU B,HAN W,LI Z,et al.Reproducibility of intra-and interscanner measurements of liver fat using complex confounder-corrected chemical shift encoded MRI at 3.0 tesla[J].Sci Rep,2016,6:19339.

[23]LI Z,SUN J,CHEN L,et al.Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging[J].J Magn Reson Imaging,2016,44(1):98-104.

[24]CHEN BB,SHIH TT.DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker[J].World J Gastroenterol,2014,20(12):3125-3134.

[25]HWANG J,KIM YK,LEE WJ,et al.Unenhanced magnetic resonance portography using repetitive arterial or vein labeling method at3.0T[J].J Comput Assist Tomogr,2013,37(6):856-861.

[26]CHEN L,YU RS.Application of Gd-EOB-DTPA enhanced magnetic resonance imaging in liver and gallbladder diseases[J].J Hepatobiliary Surg,2015,27(6):467-473.(in Chinese)陈璐,余日胜.Gd-EOB-DTPA增强磁共振在肝胆疾病中的应用现状[J].肝胆胰外科杂志,2015,27(6):467-473.

[27]LEE NK,KIM S,LEE JW,et al.Biliary MR imaging with Gd-EOB-DTPA and its clinical applications[J].Radiographics,2009,29(6):1707-1724.

[28]SMITH AD,VENIERO JC.Gd-EOB-DTPA as a functional MR cholangiography contrast agent:imaging gallbladder filling in patients with and without hepatobiliary dysfunction[J].J Comput Assist Tomogr,2011,35(4):439-445.

[29]LEE SW,CHA SH,CHUNG HH,et al.Functional magnetic resonance cholangiography with Gd-EOB-DTPA:a study in healthy volunteers[J].Magn Reson Imaging,2014,32(4):385-391.

[30]YACOUB JH,YOUSUF A,AGRAWAL G,et al.Evaluation of the gallbladder and cystic duct patency with gadoxetate disodium enhanced MR cholangiography:prospective comparison of patients with normal gallbladder function and acute cholecystitis[J].Acta Radiol,2015,56(7):782-789.

施引文献

资源附件(0)

访问统计